Worried that they are stalling the release to coincide with the half yearly (which will contain some some solid cardiocel results and give the company a chance to lay out other achievements like mena etc.).
They are either hoping the good news will outweigh the unconvincing vax results OR they want good vax news to come out with all the rest and cause a sp surge. Sabby will undoubtedly sell the second we get over 66 though so we're kinda stuck either way. At least we have the 5m which may just fight off a cap raise this year. Need a partner for the vax and we need cardiocel to fund the other product development. Hopefully a partner pays us some decent cash up front so we can stay cap raise free long term
Vax Impact???, page-11
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.80 |
Change
0.020(0.20%) |
Mkt cap ! $207.1M | |||
| Open | High | Low | Value | Volume |
| $9.85 | $10.78 | $9.60 | $572.9K | 57.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5627 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.00 | 931 | 1 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |